Dr. Rajesh Shukla, Vice President Research and Development at Seqens Talks about Controlling Impurities during API drug manufacturing.
Four Keys to Optimizing Process Research
Do's and Don'ts of API Technology Transfer in Phases 1, 2 and 3 Clinical Trials
7 things to look for in a CMO’S CGMP Manufacturing Capabilities
Massachusetts Maintains Status as Leading Life Sciences Hub
How Sponsors and CDMOs are Preparing to Manufacture APIs for Complex Generic 3 Criteria for picking ...